Evidence map›Paper›PMID 26538136›Full record

ReviewDer Radiologe2015

[Local imaging of rectal cancer--update 2015: MRI as imaging biomarker].

A-O Schäfer

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Der Radiologe, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

A-O SchäferKlinik für Diagnostische und Interventionelle Radiologie, Klinikum St. Georg Leipzig, Delitzscher Straße 141, 04129, Leipzig, Deutschland. arnd-oliver.schaefer@sanktgeorg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The significance of state of the art magnetic resonance imaging (MRI) for rectal cancer goes far beyond the detection and diagnostics of local dispersion and is increasingly focusing on patient prognosis. The identification of prognostic factors, such as tumor (T) and nodal (N) status, involvement of the circumferential resection margin, presence of extramural vascular invasion, tumor response prediction following neoadjuvant therapy, therapy-related changes in microcirculation, permeability and tissue cellularity and structured reporting are important elements of advanced rectal cancer imaging. In this context, multiparametric MRI is progressively evolving into a powerful imaging biomarker.

Indexed as

AlgorithmsHumansImage EnhancementImage Interpretation, Computer-AssistedMagnetic Resonance ImagingRectal NeoplasmsRectumReproducibility of ResultsSensitivity and SpecificityDiagnosticsMagnetic resonance imagingPrognosisRectal neoplasmsTumor staging

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.